聚乙二醇干扰素α-2a治疗慢性丙型肝炎病毒/乙型肝炎病毒共感染临床疗效

潘蕾; 魏欣; 谢玉梅; 郝春秋; 王九平; 贾战生; 白雪帆

聚乙二醇干扰素α-2a治疗慢性丙型肝炎病毒/乙型肝炎病毒共感染临床疗效

第四军医大学唐都医院全军感染病诊疗中心

基金项目:

国家“863”专项课题(2007AA02Z441)； “十一五”重大传染病防治专项课题(2009ZX10004-715)；

详细信息

中图分类号: R512.6
计量
- 文章访问数: 2593
- HTML全文浏览量: 14
- PDF下载量: 846
- 被引次数: 0
出版历程
- 出版日期: 2011-01-20

Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV

Research funding:

摘要

摘要:
目的研究慢性丙型肝炎（CHC）与丙型肝炎病毒/乙型肝炎病毒（HCV/HBV）共感染者用聚乙二醇干扰素α-2a（PEG-IFNα-2a）抗病毒治疗疗效的观察。方法治疗前后定期采集31例CHC、30例HCV/HBV共感染者的外周血,检测HCV RNA、HBV DNA和肝脏纤维化指标。结果治疗后CHC患者血清中HCV RNA含量51.6%<102拷贝/ml,HCV/HBV共感染者HCV、HBV下降均不理想。结论 PEG-IFNα-2a抗病毒治疗HCV/HBV共感染者疗效较单纯丙型肝炎患者差,但对HBV、HCV有抑制作用,并部分改善机体免疫功能及肝功能。
- 肝炎,乙型,慢性 /
- 肝炎,丙型,慢性 /
- 肝炎病毒属 /
- 肝炎病毒,乙型 /
- 干扰素α
Abstract:
Objective To evaluate the anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV.Methods We investigated 31 patients infected with HCV and 30 patients co-infected with HCV and HBV,before and after the anti-viral therapy.HCV RNA,HBV DNA and some biochemical indicators for fibrosis were detected.Results HCV-RNA showed negative in 51.6% of patients with chronic hepatitis C after therapy,but the inhibition rate of HCV RNA was lower in patients co-infected with HCV and HBV.Conclusion The PEG-IFN-α plus ribavirin therapy was effective in HCV/HBV co-infected patients,but its efficacy was not as good as in those patients only infected with HCV.But the therapy can improve the liver function of these patients.
- hepatits B /
- chronic /
- hepatitis C /
- chronic /
- hepacivirus

HTML全文

参考文献(8)

[1]Liaw YF,Chen YC,Sheen IS,et al.Impact of acute hepatitis C virus super-infection in patients with chronic hepatitis B virus infection[J].Gastroenterology,2004,126(4):1024-1029.

[2]中华医学会.丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555.

[3] 中华医学会.慢性乙型肝炎防治指南[J].中华内科杂志,2006,45(2):162-170.

[4]谢青,董志霞,项晓刚.乙型肝炎病毒和丙型肝炎病毒共感染的临床特征和治疗[J].内科理论与实践,2009,4(2):92-96.

[5]黄雁翔,陈新月,林尊慧,等.HCV/HBV共感染者抗病毒治疗分析[J].首都医科大学学报,2009,30(6):784-787.

[6]Potthoff A,Manns MP,Wedemeyer H.Treatment of HBV/HCV coinfection[J].Expert Opin Pharmacother.2010,11(6):919-928.

[7]Potthoff A,Berg T,Wedemeyer H.HEP-NET B/C Coinfection Study Group.Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin[J].Scand J Gastroenterol,2009,44(12):1487-1490.

[8]Yu JW,Sun LJ,Zhao YH,et al.Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus[J].Liver Int,2009,29(10):1485-1493.

施引文献

资源附件(0)

访问统计